Work

Experience of Relatox (botulinum toxin type A) using for chronic migraine treatment

Year: 2025

Type: article

Study design: Observational Study

Source: S S Korsakov Journal of Neurology and Psychiatry

DOI: 10.17116/jnevro2025125121134

Authors: Yu.E. Azimova, K.V. Skorobogatykh, D.Z. Korobkova, E.Z. Mamkhegov, A.S. Galanina, E.A. Guziy, A.V. Frolova, N.V. Koptenko, N.V. Vashchenko, A.S. Bazhenova, E.V. Noskov, V.V. Osipova

Institution: Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7122676125

FWCI: 1.853

Cites: 23

Cited by: 3

Related to: